Literature DB >> 6382711

Influence of HLA-A, B, and DR matching on the outcome of kidney transplant survival in preimmunized patients.

M Busson, C Raffoux, A M Bouteiller, H Betuel, A Cambom-Thomsen, D Fizet, R Fauchet, P Mercier, J Seignalet, J D Bignon.   

Abstract

The outcome of 893 prospectively typed (HLA-A, B, and DR) and matched cadaveric kidney transplants--all first grafts, with patients being transfused before transplantation--was studied using actuarial survival methods. The effect of HLA-A, B and DR matching was only found to be significantly beneficial to graft survival in the group of 289 presensitized recipients: 70% and 43% graft survival at two years in the case of best-matched (4-6 HLA-A, B, and DR) identities versus mismatched (0 and 1 HLA-A, B, and DR) identities, respectively (P = 0.05). Although a cumulative effect of matching for antigens belonging to the 3 HLA-A, B, and DR series was observed among the group of preimmunized recipients, a trend arose in favor of the prominent role of the HLA-B alleles. No significant difference related to HLA matching was observed in the group of nonsensitized recipients. These results confirm previous observations and support efforts to give priority for matched kidneys to preimmunized patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6382711     DOI: 10.1097/00007890-198409000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation.

Authors:  R J Duquesnoy; L T White; J W Fierst; M Vanek; B F Banner; Y Iwaki; T E Starzl
Journal:  Transplantation       Date:  1990-09       Impact factor: 4.939

2.  HLA Genotyping in Patients with End-Stage Renal Disease Waiting For Cadaveric Renal Transplantation in Federation of Bosnia and Herzegovina.

Authors:  Elma Fejzić; Jasenko Karamehić; Izet Eminović; Damir Suljević; Andi Alijagić; Semir Bećirević; Amela Šahović; Sanela Šišić
Journal:  Open Access Maced J Med Sci       Date:  2017-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.